Ra Pharmaceuticals (RARX) stock has risen 212.26% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives RARX stock a score of 73 out of a possible 100.
That score is chiefly influenced by a short-term technical score of 100. RARX's score also includes a long-term technical score of 100. The fundamental score for RARX is 21. In addition to the average rating from Wall Street analysts, RARX stock has a mean target price of $43.50. This means analysts expect the stock to lose 4.58% over the next 12 months.
Click Here to get the full Stock Score Report on Ra Pharmaceuticals Inc (RARX).
What's Happening with RARX Stock Today
Ra Pharmaceuticals Inc (RARX) stock is higher by 100.88% while the S&P 500 has risen 0.62% as of 10:52 AM on Thursday, Oct 10. RARX has risen $22.90 from the previous closing price of $22.70 on volume of 8,959,794 shares. Over the past year the S&P 500 has risen 1.99% while RARX has risen 212.26%. RARX lost -$2.06 per share in the over the last 12 months.
